Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Total Marrow Irradiation for Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
INCB018424 in Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML
- Status
- TERMINATED
- Phase
- PHASE1
Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- NA
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT
- Status
- COMPLETED
- Phase
- NA
Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
- Status
- UNKNOWN
- Phase
- PHASE2
A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy
- Status
- COMPLETED
- Phase
- PHASE2
Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor
- Status
- COMPLETED
- Phase
- PHASE2